Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity

References

• Beneke R, Bonning F. A case of amyloid localized to the heart. Beit Path Anat 1908; 44: 362–385
   Google Scholar
• Smith R RL, Hutchins G M, Moore G W, Humphrey R L. Type and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloidosis. Am J Med 1979; 66: 96–104
   PubMed Web of Science ®Google Scholar
• Pitkanen P, Westermark P, Cornwell G G, III. Senile systemic amyloidosis. Am J Pathol 1984; 117: 391–399
   PubMed Web of Science ®Google Scholar
• Wright J R, Calkins E. Amyloid in the aged heart: frequency and clinical significance. J Am Geriat Soc 1975; 23: 97–103
   PubMedGoogle Scholar
• Cornwell G G, III, Murdoch W L, Kyle R A, Westermark P, Pitkanen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983; 75: 618–623
   PubMed Web of Science ®Google Scholar
• Jones R S, Frazier D B. Primary cardiovascular amyloidosis. Its clinical manifestations, pathology, and histogenesis. Arch Pathol 1950; 50: 366–384
   Google Scholar
• Josselson A J, Pruitt R D, Edwards I E. Amyloid localized to the heart. Analysis of twenty-nine cases. Arch Pathol 1952; 54: 359–367
   Google Scholar
• Mulligan L M. Amyloidosis of the heart. Arch Pathol 1958; 65: 615–630
   Google Scholar
• Buerger L, Braunstein H. Senile cardiac amyloidosis. Am J Med 1960; 28: 357–367
   PubMed Web of Science ®Google Scholar
• Hodkinson H M, Pomerance A. The clinical significance of senile cardiac amyloidosis: a prospective clinico-pathological study. Quart J Med 1977; 46: 381–387
   PubMedGoogle Scholar
• Johansson B, Westermark P. Senile systemic amyloidosis: a clinico-pathological study of twelve patients with massive amyloid infiltration. Int J Cardiol 1991; 32: 83–92
   PubMed Web of Science ®Google Scholar
• Olson L J, Gertz M A, Edwards W D, Li C Y, Pellikka P A, Holmes D R, Jr., Tajik J, Kyle R A. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry. N Engl J Med 1987; 317: 738–742
   PubMed Web of Science ®Google Scholar
• Lie J T, Hammond P I. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clinic Proc 1988; 63: 552–564
   PubMed Web of Science ®Google Scholar
• Kaye G C. Isolated atrial amyloid contains atrial natriuretic peptide: a report of six cases. Br Heart J 1986; 56: 317–320
   PubMedGoogle Scholar
• Johansson B, Wernstedt C, Westermark P. Atrial natriuretic peptide deposited as atrial amyloid fibrils. Biochem Biophys Res Commun 1987; 148: 1087–1092
   PubMed Web of Science ®Google Scholar
• Johansson B, Westermark P. Isolated atrial amyloidosis. Increased frequency in patients with congestive heart failure. Amyloid and Amyloidosis 1990, Natvig JB, Forre O, Husby G, Husebekk A, Skogen B, Sletten K, et al. Kluwer Academic, Dordrecht 1991; 474–476
   Google Scholar
• Cornwell G G, III, Sletten K, Johansson B, Westermark P. Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun 1988; 154: 648–653
   PubMed Web of Science ®Google Scholar
• Westermark P, Johansson B, Natvig J B. Senile cardiac amyloidosis: evidence of two different amyloid substances in the aging heart. Scand J Immunol 1979; 10: 303–308
   PubMed Web of Science ®Google Scholar
• Kingsbury J S, Theberge R, Karbassi J A, Lim A, Costello C E, Connors L H. Detailed structural analysis of amyloidogenic wild-type transthyretin using a novel purification strategy and mass spectrometry. Anal Chem 2007; 79: 1990–1998
   PubMed Web of Science ®Google Scholar
• Gorevic P D, Prelli F C, Wright J, Pras M, Frangione B. Systemic senile amyloidosis: identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 1989; 83: 836–843
   PubMed Web of Science ®Google Scholar
• Benson M D, Wallace M R, Tejada E, Baumann H, Page B. Hereditary amyloidosis: description of a new American kindred with late onset cardiomyopathy. Arth Rheum 1987; 30: 195–200
   PubMed Web of Science ®Google Scholar
• Dupuy O, Blétry O, Blanc A S, Droz D, Viémont M, Delpech M, Grateau G. A novel variant of transthyretin (Glu42Asp) associated with sporadic late-onset cardiac amyloidosis. Amyloid 1998; 5: 285–287
   PubMed Web of Science ®Google Scholar
• Svendsen I H, Steensgaard-Hansen F, Nordvag B Y. A clinical, echocardiographic and genetic characterization of a Danish kindred with familial amyloid transthyretin methionine 111 linked cardiomyopathy [see comments]. Eur Heart J 1998; 19: 782–789
   PubMed Web of Science ®Google Scholar
• Westermark P, Sletten K, Johansson B, Cornwell G G, III. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990; 87: 2843–2845
   PubMed Web of Science ®Google Scholar
• Ritchie R F, Palomaki G E, Neveux L M, Navolotskaia O, Ledue T B, Craig W Y. Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1999; 13: 273–279
   PubMed Web of Science ®Google Scholar
• Myron Johnson A. Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition: international federation of clinical chemistry and laboratory medicine (IFCC): IFCC scientific division committee on plasma proteins (C-PP). Clin Chem Lab Med 2007; 45: 419–426
   PubMed Web of Science ®Google Scholar
• Westermark P, Pitkänen P, Benson L, Vahlquist A, Olofsson B O, Cornwell G G, III. Serum prealbumin and retinol-binding protein in the prealbumin-related senile and familial forms of systemic amyloidosis. Lab Invest 1985; 52: 314–318
   PubMed Web of Science ®Google Scholar
• Felding P, Fex G, Westermark P, Olofsson B O, Pitkänen P, Benson L. Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy. Scand J Immunol 1985; 21: 133–140
   PubMed Web of Science ®Google Scholar
• Connors L, Lim A, Prokaeva T, Roskens V A, Costello C E. Tabulation of human transthyretin (TTR) variants. Amyloid 2003; 10: 160–184
   PubMed Web of Science ®Google Scholar
• Ng B, Connors L H, Davidoff R, Skinner M, Falk R H. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005; 165: 1425–1429
   PubMed Web of Science ®Google Scholar
• Beutler E, Felitti V J, Koziol J A, Ho N J, Gelbart T. Low penetrance of the 845G->A (C282Y) HFE hereditary haemochrmatosis mutation in the United States. Lancet 2002; 359: 211–218
   PubMed Web of Science ®Google Scholar
• Van Elteren P H. On the combination of independent two-sample tests of Wilcoxon. Bull Inst Intern Stat 1960; 37: 351–361
   Google Scholar
• Kyle R A, Spittell P C, Gertz M A, Li C Y, Edwards W D, Olson L J, Thibodeau S N. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996; 101: 395–400
   PubMed Web of Science ®Google Scholar
• Jacobson D R, Pastore R D, Yaghoubian R, Kane I, Gallo G, Buck F S, Buxbaum J N. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997; 336: 466–473
   PubMed Web of Science ®Google Scholar
• Jacobson D R, Pastore R, Pool S, Malendowicz S, Kane I, Shivji A, Embury S H, Ballas S K, Buxbaum J N. Revised transthyretin Ile 122 allele frequency in African-Americans. Hum Genet 1996; 98: 236–238
   PubMed Web of Science ®Google Scholar
• Yamashita T. A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population. Amyloid 2005; 12: 127–130
   PubMed Web of Science ®Google Scholar
• Benson M D, Dwulet F E. Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis. Arthritis Rheum 1983; 26: 1493–1498
   PubMed Web of Science ®Google Scholar
• Skinner M, Connors L H, Rubinow A, Libbey C, Sipe J D, Cohen A S. Lowered prealbumin levels in patients with familial amyloid polyneuropathy (FAP) and their non-affected but at risk relatives. Am J Med Sci 1985; 289: 17–21
   PubMed Web of Science ®Google Scholar
• Almeida M R, Alves I L, Sakaki Y, Costa P P, Saraiva M JM. Prenatal diagnosis of familial amyloidotic polyneuropathy: evidence for an early expression of the associated transthyretin methionine 30. Hum Genet 1990; 85: 623–626
   PubMedGoogle Scholar
• Nakazato M, Tanaka M, Yamamura Y, Kurihara T, Matsukura S, Kangawa K, Matsuo H. Abnormal transthyretin in asymptomatic relatives in familial amyloidotic polyneuropathy. Arch Neurol 1987; 44: 1275–1278
   PubMedGoogle Scholar
• Nakazato M, Kurihara T, Matsukura S, Kangawa K, Matsuo H. Diagnostic radioimmunoassay for familial amyloidotic polyneuropathy before clinical onset. J Clin Invest 1986; 77: 1699–1703
   PubMedGoogle Scholar
• McEntegart M B. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 2007; 28: 829–835
   PubMedGoogle Scholar
• Strassburg S, Anker S D. Metabolic and immunologic derangements in cardiac cachexia: where to from here?. Heart fail Rev 2006; 11: 57–64
   PubMedGoogle Scholar
• Bartalena L, Farsetti A, Flink I L, Robbins J. Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells. Mol Endocrinol 1992; 6: 935–942
   PubMedGoogle Scholar
• Yoshida A. Analysis of the factors contributing to serum retinol binding protein and transthyretin levels in Japanese adults. J Atheroscler Thromb 2006; 13: 209–215
   PubMedGoogle Scholar
• Cohen H J, Pieper C F, Harris T, Rao K M, Currie M S. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 1997; 52: M201–M208
   PubMed Web of Science ®Google Scholar
• Rimessi P, Spitali P, Ando Y, et al. Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic polyneuropathy, and identification of a dual transcription start point. Liver Int 2006; 26: 211–220
   PubMedGoogle Scholar
• Mita S. Analyses of prealbumin mRNAs in individuals with familial amyloidotic polyneuropathy. J Biochem 1986; 100: 1215–1222
   PubMedGoogle Scholar
• Hanes D, Zech L A, Murrell J, Benson M D. Metabolism of normal and MET30 transthyretin. Adv Food Nutr Res 1996; 40: 149–153
   PubMedGoogle Scholar
• Longo A I, Hays M T, Saraiva M J. Comparative stability and clearance of [Met30]transthyretin and [Met119]transthyretin. Eur J Biochem 1997; 249: 662–668
   PubMedGoogle Scholar
• Makover A, Moriwaki H, Ramakrishnan R, Saraiva M J, Blaner W S, Goodman D S. Plasma transthyretin. Tissue sites of degradation and turnover in the rat. J Biol Chem 1988; 263: 8598–8603
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Tokuda T, Kametani F, Tanaka K, Maruyama K, Ikeda S. Serum transthyretin monomer in patients with familial amyloid polyneuropathy. Amyloid 2001; 8: 257–262
   PubMed Web of Science ®Google Scholar
• Stangou A J, Heaton N D, Hawkins P N. Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. N Engl J Med 2005; 352: 2356
   PubMed Web of Science ®Google Scholar
• Wiseman R L, Powers E T, Buxbaum J N, Kelly J W, Balch W E. An adaptable standard for protein export from the endoplasmic reticulum. Cell 2007; 131: 809–821
   PubMed Web of Science ®Google Scholar